Patent details

Basic Information

Publication number:

EP2663189

PCT Application Number:

US2012020863

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP127339166

PCT Publication Number:

WO2012097021

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMBINATION OF BORTEZOMIB WITH AFURESERTIB AND USE THEREOF IN THE TREATMENT OF CANCER

French Title of Invention:

COMBINAISON DE BORTEZOMIB AVEC L'AFURESERTIB ET UTILISATION DE CELLE-CI DANS LE TRAITEMENT DU CANCER

German Title of Invention:

KOMBINATION VON BORTEZOMIB MIT AFURESERTIB UND DESSEN VERWENDUNG ZUR BEHANDLUNG VON KREBS

SPC Number:

Dates

Filing date:

11/01/2012

Grant date:

04/07/2018

EP Publication Date:

20/11/2013

PCT Publication Date:

19/07/2012

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

04/07/2018

EP B1 Publication Date:

04/07/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

11/01/2019

Expiration date:

11/01/2032

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

27/06/2018

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

Name:

KUMAR, Rakesh

Address:

United States (US)

Priority

Priority Number:

201161431508 P

Priority Date:

11/01/2011

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/4155; A61K 31/69; A61K 45/06; A61P 35/00;

Publication

European Patent Bulletin

Issue number:

201827

Publication date:

04/07/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
31/05/2019	Outgoing Correspondence	1